Clinical Trial Update: Fecal Microbiota Transfer to Improve Diabetes Control Post-bariatric Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating fecal microbiota transfer to improve diabetes control after bariatric surgery; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Fecal Microbiota Transfer (fecal microbiota transplantation)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Bariatric Surgery, Type 2 Diabetes | Phase 3 | Status: RECRUITING